¡Atención! Este sitio usa cookies y tecnologías similares.

Si no cambia la configuración de su navegador, usted acepta su uso. Saber más

Acepto

Bibliografía

Bibliografía glutatión

 

  • Allen, J. (2008). "Inhaled glutathione for the prevention of air pollution-related health effects: a brief review." Altern Ther Health Med 14(3): 42-44.
  • Arosio, E., S. De Marchi, et al. (2002). "Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial." Mayo Clin Proc 77(8): 754-759.
  • Atkuri, K. R., J. J. Mantovani, et al. (2007). "N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency." Curr Opin Pharmacol 7(4): 355-359.
  • Balendiran, G. K., R. Dabur, et al. (2004). "The role of glutathione in cancer." Cell Biochem Funct 22(6): 343-352.
  • Barlow-Walden, L. R., R. J. Reiter, et al. (1995). "Melatonin stimulates brain glutathione peroxidase activity." Neurochem Int 26(5): 497-502.
  • Barrios, V., A. Calderon, et al. (2002). "N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients." Blood Press 11(4): 235-239.
  • Biswas, S. K. and I. Rahman (2009). "Environmental toxicity, redox signaling and lung inflammation: the role of glutathione." Mol Aspects Med 30(1-2): 60-76.
  • Blanco, R. A., T. R. Ziegler, et al. (2007). "Diurnal variation in glutathione and cysteine redox states in human plasma." Am J Clin Nutr 86(4): 1016-1023.
  • Bounous, G., S. Baruchel, et al. (1993). "Whey proteins as a food supplement in HIV-seropositive individuals." Clin Invest Med 16(3): 204-209.
  • Bounous, G. and P. Gold (1991). "The biological activity of undenatured dietary whey proteins: role of glutathione." Clin Invest Med 14(4): 296-309.
  • Chen, Y., Y. Yang, et al. (2007). "Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure." Hepatology 45(5): 1118-1128.
  • Chow, H. H., I. A. Hakim, et al. (2007). "Modulation of human glutathione s-transferases by polyphenon e intervention." Cancer Epidemiol Biomarkers Prev 16(8): 1662-1666.
  • De Benedetto, F., A. Aceto, et al. (2005). "Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD." Pulm Pharmacol Ther 18(1): 41-47.
  • Droge, W. and E. Holm (1997). "Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction." FASEB J 11(13): 1077-1089.
  • Edwards, A. T., A. D. Blann, et al. (1994). "Systemic responses in patients with intermittent claudication after treadmill exercise." Br J Surg 81(12): 1738-1741.
  • Escobar, J., J. Pereda, et al. (2009). "Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: a key role for protein phosphatases." Curr Pharm Des 15(26): 3027-3042.
  • Foschino Barbaro, M. P., G. Serviddio, et al. (2005). "Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine." Free Radic Res 39(10): 1111-1118.
  • Grandjean, E. M., P. Berthet, et al. (2000). "Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials." Clin Ther 22(2): 209-221.
  • Grey, V., S. R. Mohammed, et al. (2003). "Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein." J Cyst Fibros 2(4): 195-198.
  • Gross, C. L., J. K. Innace, et al. (1993). "Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard." Cell Biol Toxicol 9(3): 259-267.
  • Han, Y. H. and W. H. Park (2009). "The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione." Oncol Rep 22(2): 385-391.
  • Hansel, B., A. Kontush, et al. (2006). "Alterations in lipoprotein defense against oxidative stress in metabolic syndrome." Curr Atheroscler Rep 8(6): 501-509.
  • Herzenberg, L. A., S. C. De Rosa, et al. (1997). "Glutathione deficiency is associated with impaired survival in HIV disease." Proc Natl Acad Sci U S A 94(5): 1967-1972.
  • Hoshino, T., M. Okamoto, et al. (2008). "Redox-regulated mechanisms in asthma." Antioxid Redox Signal 10(4): 769-783.
  • Kaneto, H., Y. Kajimoto, et al. (1999). "Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity." Diabetes 48(12): 2398-2406.
  • Kasielski, M. and D. Nowak (2001). "Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease." Respir Med 95(6): 448-456.
  • Lieber, C. S. (2002). "S-adenosyl-L-methionine: its role in the treatment of liver disorders." Am J Clin Nutr 76(5): 1183S-1187S.
  • Loguercio, C., G. Nardi, et al. (1994). "Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease." Alcohol Alcohol 29(5): 597-604.
  • London, S. J. (2007). "Gene-air pollution interactions in asthma." Proc Am Thorac Soc 4(3): 217-220.
  • Maczurek, A., K. Hager, et al. (2008). "Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease." Adv Drug Deliv Rev 60(13-14): 1463-1470.
  • Manna, P., M. Sinha, et al. (2008). "Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid." Arch Toxicol 82(3): 137-149.
  • Marazzi, G., S. Rosanio, et al. (2008). "The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure." Curr Pharm Des 14(25): 2592-2604.
  • Marchetti, A. and R. Rossiter (2009). "Managing acute acetaminophen poisoning with oral versus intravenous N-acetylcysteine: a provider-perspective cost analysis." J Med Econ 12(4): 384-391.
  • Martina, V., A. Masha, et al. (2008). "Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes." Diabetes Care 31(5): 940-944.
  • Mastruzzo, C., N. Crimi, et al. (2002). "Role of oxidative stress in pulmonary fibrosis." Monaldi Arch Chest Dis 57(3-4): 173-176.
  • Micke, P., K. M. Beeh, et al. (2002). "Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients." Eur J Nutr 41(1): 12-18.
  • Micke, P., K. M. Beeh, et al. (2001). "Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients." Eur J Clin Invest 31(2): 171-178.
  • Moreno, Y. F., V. C. Sgarbieri, et al. (2006). "Features of whey protein concentrate supplementation in children with rapidly progressive HIV infection." J Trop Pediatr 52(1): 34-38.
  • Nadeem, A., A. Masood, et al. (2008). "Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options." Ther Adv Respir Dis 2(4): 215-235.
  • Nencini, C., G. Giorgi, et al. (2007). "Protective effect of silymarin on oxidative stress in rat brain." Phytomedicine 14(2-3): 129-135.
  • Newman, K. P., M. T. Neal, et al. (2007). "The importance of lost minerals in heart failure." Cardiovasc Hematol Agents Med Chem 5(4): 295-299.
  • Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. Br J Biomed Sci. 2007;64:35-43.
  • Ozaydin, M., O. Peker, et al. (2008). "N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study." Eur Heart J 29(5): 625-631.
  • Papi, A., F. Luppi, et al. (2006). "Pathophysiology of exacerbations of chronic obstructive pulmonary disease." Proc Am Thorac Soc 3(3): 245-251.
  • Paravicini, T. M. and R. M. Touyz (2006). "Redox signaling in hypertension." Cardiovasc Res 71(2): 247-258.
  • Parodi, O., R. De Maria, et al. (2007). "Redox state, oxidative stress and endothelial dysfunction in heart failure: the puzzle of nitrate-thiol interaction." J Cardiovasc Med (Hagerstown) 8(10): 765-774.
  • Pastore, A., F. Piemonte, et al. (2001). "Determination of blood total, reduced, and oxidized glutathione in pediatric subjects." Clin Chem 47(8): 1467-1469.
  • Pereira, C. F. and C. R. Oliveira (2000). "Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis." Neurosci Res 37(3): 227-236.
  • Perricone, C., C. De Carolis, et al. (2009). "Glutathione: a key player in autoimmunity." Autoimmun Rev 8(8): 697-701.
  • Pessah-Rasmussen, H., L. Stavenow, et al. (1990). "Lack of glutathione transferase activity in intermittent claudication." Int Angiol 9(2): 70-74.
  • Pompella, A., A. Visvikis, et al. (2003). "The changing faces of glutathione, a cellular protagonist." Biochem Pharmacol 66(8): 1499-1503.
  • Rahman, I. (2008). "Antioxidant therapeutic advances in COPD." Ther Adv Respir Dis 2(6): 351-374.
  • Rottner, M., J. M. Freyssinet, et al. (2009). "Mechanisms of the noxious inflammatory cycle in cystic fibrosis." Respir Res 10: 23.
  • Rush, J. W. and R. J. Ford (2007). "Nitric oxide, oxidative stress and vascular endothelium in health and hypertension." Clin Hemorheol Microcirc 37(1-2): 185-192.
  • Salinthone, S., V. Yadav, et al. (2008). "Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS." Endocr Metab Immune Disord Drug Targets 8(2): 132-142.
  • Sampsonas, F., M. A. Archontidou, et al. (2007). "Genetic alterations of glutathione S-transferases in asthma: do they modulate lung growth and response to environmental stimuli?" Allergy Asthma Proc 28(3): 282-286.
  • Saviuc, P. and V. Danel (2008). "[Acute acetaminophen overdose]." Rev Prat 58(8): 861-865.
  • Scanu, A. M. and C. Edelstein (2008). "HDL: bridging past and present with a look at the future." FASEB J 22(12): 4044-4054.
  • Sener, G., A. Sakarcan, et al. (2007). "Role of garlic in the prevention of ischemia-reperfusion injury." Mol Nutr Food Res 51(11): 1345-1352.
  • Shangari, N., W. R. Bruce, et al. (2003). "Toxicity of glyoxals--role of oxidative stress, metabolic detoxification and thiamine deficiency." Biochem Soc Trans 31(Pt 6): 1390-1393.
  • Shay, K. P., R. F. Moreau, et al. (2009). "Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential." Biochim Biophys Acta 1790(10): 1149-1160.
  • Singh, U. and I. Jialal (2008). "Alpha-lipoic acid supplementation and diabetes." Nutr Rev 66(11): 646-657.
  • Sisillo, E., R. Ceriani, et al. (2008). "N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial." Crit Care Med 36(1): 81-86.
  • Stey, C., J. Steurer, et al. (2000). "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review." Eur Respir J 16(2): 253-262.
  • Thornalley, P. J. (2007). "Endogenous alpha-oxoaldehydes and formation of protein and nucleotide advanced glycation endproducts in tissue damage." Novartis Found Symp 285: 229-243; discussion 243-226.
  • Tsutsui, H., S. Kinugawa, et al. (2009). "Mitochondrial oxidative stress and dysfunction in myocardial remodelling." Cardiovasc Res 81(3): 449-456.
  • Valenzuela, A., M. Aspillaga, et al. (1989). "Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat." Planta Med 55(5): 420-422.
  • Vendemiale, G., E. Altomare, et al. (1989). "Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease." Scand J Gastroenterol 24(4): 407-415.
  • Vincent, H. K., K. E. Innes, et al. (2007). "Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity." Diabetes Obes Metab 9(6): 813-839.
  • Witschi, A., S. Reddy, et al. (1992). "The systemic availability of oral glutathione." Eur J Clin Pharmacol 43(6): 667-669.
  • www.immunocal.com. (2009). "PDR® entry for Immunocal Powder Sachets (Immunotec)." Retrieved 17-Dec, 2009, from http://www.drugs.com/pdr/immunocal-powder-sachets.html.
  • Yung, L. M., F. P. Leung, et al. (2006). "Reactive oxygen species in vascular wall." Cardiovasc Hematol Disord Drug Targets 6(1): 1-19.